Keywords:
trend study
nonsteroidal anti-inflammatory drugs
research cluster
health and wellbeing

  • Abstract

    The commonly used class of pharmaceuticals known as nonsteroidal anti-inflammatory drugs (NSAIDs) has important effects on the treatment of pain and the decrease of inflammation. Medical progress and public health depend on an understanding of the patterns, areas of study, and effects of NSAIDs. To determine current research trends, this study uses Scopus to look up published articles on NSAIDs from 2018 to 2023. By emphasizing areas of increased interest and revealing gaps that could guide future study, bibliometric analysis allows us to get insights into the changing environment of NSAID research. With this strategy, new health issues are addressed, and the corpus of research is maintained to support educated medical practices. The most referenced articles, journal-related performance, trends in publishing and citation performance, and developing research cluster keywords were all analyzed in this study. The goals of the study were attained by using a bibliometric analysis that was directed by four research questions. Using Microsoft Excel, VOSviewer, and Harzing's Publish or Perish tools, the study first extracted information and examined keyword co-occurrence. To determine themes and dimensions from the keyword clusters found by VOSviewer, content analysis was also done. The findings revealed eleven new study term clusters on NSAIDS, such as: (a) 2020 had the highest number of NSAIDS citations, followed by 2019 and 2018. (b) In 2023, PLos One, Pharmaceutical, Chemosphere, and the Cochrane Database of Systematic Reviews published sixteen referenced journals on NSAIDS. (c) the top ten papers cited from 2018 to 2023, with 2020 having the most citations (782), (d) Ten clusters that emerged from the 42 NSAIDS-related titles, yielding ten dimensions (e.g., Optimized Pain Management; Therapeutic Expansion's Cardiovascular Safety; Changing Knowledge of NSAID Safety). As a result, suggestions are made for additional research to broaden and deepen this important area.

  • References

    1. Al-Ahmad, M., Rodriguez-Bada, J. L., Del Pozo, V., Doña, I., Zambonino, M. A., Gaig, P., & Blanca, M. (2014). Allergy-like immediate reactions and anaphylaxis induced by nonsteroidal anti-inflammatory drugs: Clinical features and risk factors. Clinical and Experimental Allergy, 44(6), 736–746. https://doi.org/10.1111/cea.12275
    2. Aldington, D., & McQuay, H. (2018). Systematic review of the efficacy and safety of oral paracetamol (acetaminophen) and oral nonsteroidal anti-inflammatory drugs for chronic low back pain. Pain Practice, 14(1), 59–70. https://doi.org/10.1111/papr.12583
    3. Antman, E. M., Bennett, J. S., Daugherty, A., Furberg, C., Roberts, H., & Taubert, K. A. (2017). Use of nonsteroidal anti-inflammatory drugs: An update for clinicians: A scientific statement from the American Heart Association. Circulation, 115(12), 1634–1642. https://doi.org/10.1161/CIRCULATIONAHA.106.181424
    4. Aria, M., & Cuccurullo, C. (2017). Bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of Informetrics, 11(4), 959–975. https://doi.org/10.1016/j.joi.2017.08.007
    5. Baker, M., Perazella, M. A., & Sise, M. E. (2020). NSAIDs in CKD: Are they safe? American Journal of Kidney Diseases, 76(4), 546–557. https://doi.org/10.1053/j.ajkd.2020.03.023
    6. Bennett-Guerrero, E., Welsby, I., Dunn, T. J., Young, L. R., Berry, W. R., Brady, K. M., & Newman, M. F. (2014). The use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the perioperative period: A meta-analysis. Journal of Clinical Anesthesia, 26(8), 621–629. https://doi.org/10.1111/coa.12106
    7. Bhala, N., Emberson, J., Merhi, A., Abramson, S., Arber, N., Baron, J. A., & Baigent, C. (2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. The Lancet, 382(9894), 769–779. https://doi.org/10.1016/S0140-6736(13)60900-9
    8. Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020). Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical Pharmacology, 180, 114147. https://doi.org/10.1016/j.bcp.2020.114147
    9. Bjarnason, I., Scarpignato, C., Holmgren, E., Olszewski, M., Rainsford, K. D., & Lanas, A. (2018). Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology, 154(3), 500–514. https://doi.org/10.1053/j.gastro.2017.10.049
    10. Bongartz, T., Halligan, C. S., Osmon, D. R., Reinalda, M. S., O’Laughlin, E. D., Hanssen, A. D., & Steckelberg, J. M. (2014). Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis & Rheumatism, 59(12), 1713–1720. https://doi.org/10.1002/art.24060
    11. Bornmann, L., & Daniel, H. D. (2008). What do citation counts measure? A review of studies on citing behavior. Journal of Documentation, 64(1), 45–80. https://doi.org/10.1108/00220410810844150
    12. Brune, K., & Patrignani, P. (2015). New insights into the use of currently available non-steroidal anti-inflammatory drugs. Journal of Pain Research, 8, 105–118. https://doi.org/10.2147/JPR.S75160
    13. Busse, J. W., Wang, L., Kamaleldin, M., Craigie, S., Riva, J. J., Montoya, L., & Guyatt, G. H. (2018). Opioids for chronic noncancer pain: A systematic review and meta-analysis. JAMA, 320(23), 2448–2460. https://doi.org/10.1001/jama.2018.18472
    14. Buvanendran, A., Kroin, J. S., Della Valle, C. J., Kari, M., Moric, M., Tuman, K. J., & Kroin, J. S. (2010). Celecoxib use in the perioperative period for total knee arthroplasty: Effect on recovery of function and postoperative pain control. Journal of Bone and Joint Surgery, 92(6), 1163–1170. https://doi.org/10.1186/1471-2474-9-77
    15. Cao, Y., Nishihara, R., Wu, K., Wang, M., Ogino, S., Willett, W. C., & Chan, A. T. (2018). Population-wide impact of long-term use of aspirin and other non-steroidal anti-inflammatory drugs on the risk for cancer. JAMA Oncology, 2(12), 1150–1159. https://doi.org/10.1001/jamaoncol.2015.6396
    16. Chan, A. T., Ogino, S., & Fuchs, C. S. (2011). Aspirin use and survival after diagnosis of colorectal cancer. JAMA, 305(11), 1119–1126. https://doi.org/10.1001/jama.2011.338
    17. Cheng, Y. M., Tsai, Y. T., Chen, J. F., Lee, C. H., & Hsu, H. C. (2018). Nonsteroidal anti-inflammatory drugs and risk of first hospitalization for heart failure in patients with no history of heart failure: A population-based case-crossover study. Journal of Cardiovascular Pharmacology and Therapeutics, 23(1), 54–61. https://doi.org/10.1177/1074248417703222
    18. Chiong, H. S., Nazrul Hakim, M., Sulaiman, M. R., Zakaria, Z. A., Zuraini, A., Ong, S. G. M., & Yuen, K. H. (2011). Development and characterisation study of liposomes-encapsulated piroxicam. International Journal of Drug Delivery, 3(1), 64–73. https://doi.org/10.13005/bpj/2905
    19. Chiong, H. S., Yong, Y. K., Hijaz, M. S. M., Sulaiman, M. R., Yuen, K. H., & Hakim, M. N. (2024). Improved anti-nociceptive, anti-pyretic and anti-inflammatory effects of orally administered liposome-encapsulated piroxicam. Biomedical Pharmacology Journal, 17(2), 795–811. https://doi.org/10.13005/bpj/2905
    20. Coxib and traditional NSAID Trialists' (CNT) Collaboration; Bhala, N., Emberson, J., Merhi, A., Abramson, S., Arber, N., Baron, J. A., Bombardier, C., Cannon, C., Farkouh, M. E., FitzGerald, G. A., Goss, P., Halls, H., Hawk, E., Hawkey, C., Hennekens, C., Hochberg, M., Holland, L. E., Kearney, P. M., Laine, L., Lanas, A., Lance, P., Laupacis, A., Oates, J., Patrono, C., Schnitzer, T. J., Solomon, S., Tugwell, P., Wilson, K., Wittes, J., & Baigent, C. (2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. The Lancet, 382(9894), 769–779. https://doi.org/10.1016/S0140-6736(13)60900-9
    21. Creswell, J. W., & Plano Clark, V. L. (2017). Designing and conducting mixed methods research (3rd ed.). Sage Publications.
    22. Cryer, B., & Feldman, M. (2010). Effects of very low-dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels. Digestive Diseases and Sciences, 35(3), 323–326. https://doi.org/10.1016/s0016-5085(99)70545-7
    23. Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., & Thun, M. (2014). Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: An international consensus statement. The Lancet Oncology, 10(5), 501–507. https://doi.org/10.1016/S1470-2045(09)70035-X
    24. Dahl, J. B., Møiniche, S., & Kehlet, H. (2010). Pre-emptive analgesia. British Journal of Anaesthesia, 87(1), 142–150. https://doi.org/10.1093/bja/70.4.434
    25. Derry, S., Conaghan, P., Da Silva, J. A. P., Wiffen, P. J., & Moore, R. A. (2017). Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews, 4(4), CD007400. https://doi.org/10.1002/14651858.CD007400.pub3
    26. Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research, 133, 285–296. https://doi.org/10.1016/j.jbusres.2021.04.070
    27. Elizalde-Velázquez, A., & Gómez-Oliván, L. M. (2020). Sorption of three common nonsteroidal anti-inflammatory drugs (NSAIDs) to microplastics. Science of the Total Environment, 748, 141180. https://doi.org/10.1016/j.scitotenv.2020.136974
    28. Elmallah, R. K., Chughtai, M., Khlopas, A., Newman, J. M., Stearns, K. L., Roche, M. W., & Mont, M. A. (2017). Pain control in total knee arthroplasty. Journal of Knee Surgery, 31(7), 504–513. https://doi.org/10.1055/s-0037-1604152
    29. Evans, A. E. V., Mateo-Sagasta, J., Qadir, M., Boelee, E., & Ippolito, A. (2019). Agricultural water pollution: Key knowledge gaps and research needs. Current Opinion in Environmental Sustainability, 36, 20–27. https://doi.org/10.1016/j.cosust.2018.10.003
    30. Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008). Comparison of PubMed, Scopus, Web of Science, and Google Scholar: Strengths and weaknesses. The FASEB Journal, 22(2), 338–342. https://doi.org/10.1096/fj.07-9492LSF
    31. Franceschet, M. (2009). A cluster analysis of scholar and journal bibliometric indicators. Journal of the American Society for Information Science and Technology, 60(10), 1950–1964. https://doi.org/10.1002/asi.21152
    32. Gaffney, V. C., Almeida, C. M., Rodrigues, A., Ferreira, S., & Benoliel, M. J. (2015). Occurrence of pharmaceuticals in a water supply system and related human health risk assessment. Water Research, 72, 199–210. https://doi.org/10.1016/j.watres.2014.10.027
    33. Gan, T. J., Habib, A. S., Miller, T. E., White, W., & Apfelbaum, J. L. (2014). Incidence, patient satisfaction, and perceptions of post-surgical pain: Results from a US national survey. Current Medical Research and Opinion, 30(1), 149–160. https://doi.org/10.1185/03007995.2013.860019
    34. García-Rayado, G., Navarro, M., & Lanas, A. (2018). NSAID-induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Review of Clinical Pharmacology, 11(10), 1031–1043. https://doi.org/10.1080/17512433.2018.1516143
    35. Goh, J. Z., Tang, S. N., Zuraini, A., Zakaria, Z. A., Kadir, A. A., Chiong, H. S., Fauzee, M. S. O., & Hakim, M. N. (2013). Enhanced anti-inflammatory effects of nanoencapsulated diclofenac. European Journal of Inflammation, 11(3), 855–861. https://doi.org/10.1177/1721727X1301100328
    36. González, J. R., Garcia-Martin, E., & Agundez, J. A. (2023). Pharmacogenetics of nonsteroidal anti-inflammatory drugs. Pharmacogenomics Journal, 12, 462–467. https://doi.org/10.1038/tpj.2012.40
    37. Greenhalgh, T., Thorne, S., & Malterud, K. (2016). Time to challenge the spurious hierarchy of systematic over narrative reviews? European Journal of Clinical Investigation, 48(6), 427–429. https://doi.org/10.1111/eci.12931
    38. Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017). Chronic opioid use after surgery: Implications for perioperative management in the face of the opioid epidemic. Anesthesia & Analgesia, 125(5), 1733–1740. https://doi.org/10.1213/ANE.0000000000002458
    39. Hakim, M. N. (2022). Life without ADRs?: Adverse drug reactions. UPM Press.
    40. Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., & Tugwell, P. (2012). American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care & Research, 64(4), 465–474. https://doi.org/10.1002/acr.21596
    41. Hughes, S. R., Kay, P., & Brown, L. E. (2013). Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environmental Science & Technology, 47(2), 661–677. https://doi.org/10.1021/es3030148
    42. Hunt, R. H., Choquette, D., Craig, B. N., Dao, H. H., Davies, G. E., Fortin, P. R., & Tannenbaum, H. (2015). Consensus guidelines for the prevention and management of upper gastrointestinal and renal toxicity associated with nonsteroidal anti-inflammatory drugs. Alimentary Pharmacology & Therapeutics, 32(4), 472–487. https://doi.org/10.5005/jp-journals-10018-1281
    43. Hunt, R. H., Choquette, D., Craig, B. N., Dobson, H., Erlich, J., Flook, N., & Tytgat, G. N. (2010). A Canadian consensus: The rational, safe and effective use of nonsteroidal anti-inflammatory drugs (NSAIDs) & cyclooxygenase-2 (COX-2) inhibitors in the treatment of inflammatory musculoskeletal conditions. Canadian Journal of Gastroenterology, 24(9), 621–630. https://doi.org/10.1111/j.1365-2036.2008.03905.x
    44. Kehlet, H., & Dahl, J. B. (2017). The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesthesia & Analgesia, 77(5), 1048–1056. https://doi.org/10.1213/00000539-199311000-00030
    45. Kehlet, H., & Wilmore, D. W. (2002). Multimodal strategies to improve surgical outcome. The American Journal of Surgery, 183(6), 630–641. https://doi.org/10.1016/S0002-9610(02)00866-8
    46. Kirby, A. (2023). Exploratory bibliometrics: Using VOSviewer as a preliminary research tool. Publications, 11(1), 10. https://doi.org/10.3390/publications11010010
    47. Klomjit, N., & Ungprasert, P. (2022). Acute kidney injury associated with non-steroidal anti-inflammatory drugs. European Journal of Internal Medicine, 101, 21–28. https://doi.org/10.1016/j.ejim.2022.05.003
    48. Kowalski, M. L., Asero, R., Bavbek, S., Blanca, M., Blanca-López, N., Bochenek, G., & Torres, M. J. (2013). Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy, 68(10), 1219–1232. https://doi.org/10.1111/all.12260
    49. Krippendorff, K. (2018). Content analysis: An introduction to its methodology (4th ed.). Sage Publications.
    50. Kumari, S., Panda, P. K., Pradhan, S., & Mishra, A. (2018). Emerging therapeutic strategies for enhancement of NSAIDs efficiency as an anticancer agent. Biomedicine & Pharmacotherapy, 107, 1425–1436.
    51. Kümmerer, K. (2019). Pharmaceuticals in the environment: Sources, fate, effects, and risks. Springer-Verlag.
    52. Lanza, F. L., Chan, F. K., & Quigley, E. M. M. (2009). Guidelines for prevention of NSAID related ulcer complications. The American Journal of Gastroenterology, 104(3), 728–738. https://doi.org/10.1038/ajg.2009.115
    53. Lim, W. M., Kumar, S., & Donthu, N. (2024). How to combine and clean bibliometric data and use bibliometric tools synergistically: Guidelines using metaverse research. Journal of Business Research, 182, 114760. https://doi.org/10.1016/j.jbusres.2024.114760
    54. Mahmud, S. M., Franco, E. L., & Aprikian, A. G. (2014). Prostate cancer and use of nonsteroidal anti-inflammatory drugs: Systematic review and meta-analysis. British Journal of Cancer, 90(1), 93–99. https://doi.org/10.1038/sj.bjc.6601416
    55. Margot, J., Rossi, L., Barry, D. A., & Holliger, C. (2015). A review of the fate of micropollutants in wastewater treatment plants. Water Research, 89, 91–106. https://doi.org/10.1002/wat2.1090
    56. McCreary, E. K., & Pogue, J. M. (2020). Coronavirus disease 2019 treatment: A review of early and emerging options. Open Forum Infectious Diseases, 7(4), ofaa105. https://doi.org/10.1093/ofid/ofaa105
    57. McEvoy, M. D., Scott, M. J., Gordon, D. B., Grant, S. A., Thacker, J. K. M., Wu, C. L., Gan, T. J., Mythen, M. G., Shaw, A. D., & Miller, T. E. (2017). Perioperative Quality Initiative (POQI) I Workgroup. American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) joint consensus statement on optimal analgesia within an enhanced recovery pathway for colorectal surgery: Part 1—from the preoperative period to PACU. Perioperative Medicine, 6, Article 8. https://doi.org/10.1186/s13741-017-0064-5
    58. McGettigan, P., & Henry, D. (2013). Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA, 296(13), 1633–1644. https://doi.org/10.1001/jama.296.13.1633
    59. Minghelli, G., Sogni, F., Rosa, M., Vella, D., & Reginelli, M. (2018). NSAIDs and gastrointestinal risk factors: A review of the literature. Journal of Pharmacology & Pharmacotherapeutics, 6(2), 96–102. https://doi.org/10.1097/MD.0000000000010665
    60. Moed, H. F. (2005). Citation analysis in research evaluation. Springer. https://link.springer.com/book/10.1007/1-4020-3714-7
    61. Mongeon, P., & Paul Hus, A. (2016). The journal coverage of Web of Science and Scopus: A comparative analysis. Scientometrics, 106, 213–228. https://doi.org/10.1007/s11192-015-1765-5
    62. Moore, R. A., Derry, S., McQuay, H. J., & Wiffen, P. J. (2014). Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database of Systematic Reviews, 2014(8), CD008659. https://doi.org/10.1002/14651858.CD008659.pub3
    63. Moore, R. A., Derry, S., McQuay, H. J., & Wiffen, P. J. (2015). Combination analgesic efficacy with NSAIDs, opioids, and paracetamol (acetaminophen). Cochrane Database of Systematic Reviews, 2015(9), CD010644. https://doi.org/10.1002/14651858.CD010644
    64. Nissen, S. E., Yeomans, N. D., Solomon, D. H., Lüscher, T. F., Libby, P., Husni, M. E., & Cannon, C. P. (2016). Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. The New England Journal of Medicine, 375(26), 2519–2529. https://doi.org/10.1056/NEJMoa1611593
    65. Parolini, M. (2020). Toxicity of the non steroidal anti inflammatory drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review. Science of the Total Environment, 740, 140043. https://doi.org/10.1016/j.scitotenv.2020.140043
    66. Piazza, G. A., Keeton, A. B., Tinsley, H. N., Gary, B. D., Whitt, J. D., Mathew, B., & Duckett, D. R. (2015). NSAIDs: Old drugs reveal new anticancer mechanisms. Gut, 58(8), 1174–1183. https://doi.org/10.3390/ph3051652 (nota: DOI apontava para MDPI; potencial incongruência com o periódico Gut)
    67. Rainsford, K. D. (2013). Ibuprofen: Pharmacology, efficacy, and safety. Inflammopharmacology, 17(6), 275–342. https://doi.org/10.1007/s10787-009-0016-x
    68. Ricciotti, E., & FitzGerald, G. A. (2011). Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 986–1000. https://doi.org/10.1161/ATVBAHA.110.207449
    69. Rothwell, P. M., Fowkes, F. G. R., Belch, J. F. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011). Effect of daily aspirin on long term risk of death due to cancer: Analysis of individual patient data from randomized trials. The Lancet, 379(9826), 1602–1612. https://doi.org/10.1016/S0140-6736(10)62110-1
    70. Russell, B., Moss, C., George, G., Santaolalla, A., Cope, A., Papa, S., & Van Hemelrijck, M. (2020). COVID 19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting? ecancermedicalscience, 14, Article 1023. https://doi.org/10.3332/ecancer.2020.1023
    71. Salinas-Ríos, K., & Lopez, A. J. G. (2022). Bibliometrics, a useful tool within the field of research. Journal of Basic and Applied Psychology Research, 3(6), 9–16. https://doi.org/10.55057/jbapr.v3i6.6829
    72. Schjerning, A. M., McGettigan, P., & Gislason, G. (2020). Cardiovascular effects and safety of (non aspirin) NSAIDs. Nature Reviews Cardiology, 17, 574–584. https://doi.org/10.1038/s41569-020-0366-z
    73. Seglen, P. O. (1997). Why the impact factor of journals should not be used for evaluating research. British Medical Journal, 314(7079), 498–502. https://doi.org/10.1136/bmj.314.7079.497
    74. Sinkovics, N. (2016). Enhancing the foundations for theorising through bibliometric mapping. International Marketing Review, 33(3), 327–350. https://doi.org/10.1108/IMR-10-2014-0341
    75. Smalley, W., & DuBois, R. N. (2016). Colorectal cancer and nonsteroidal anti-inflammatory drugs. Advances in Pharmacology, 76, 111–138. https://doi.org/10.1016/S1054-3589(08)60067-8
    76. Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Mansi, N., Habib, A., Abdin, Z. U., Chaudhry, W. R., & Akber, A. (2023). Effects of non steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: A narrative review. Cureus, 15(4), e37080. https://doi.org/10.7759/cureus.37080
    77. Solomon, S. D., Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., & Cross Trial Safety Assessment Cluster. (2017). Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: The cross trial safety analysis. Circulation, 117(16), 2104–2113. https://doi.org/10.1161/CIRCULATIONAHA.108.764530
    78. Somchit, M. N., Sanat, F., Gan, E. H., Wahab, S. I., & Ahmad, Z. (2014). Mefenamic acid induced nephrotoxicity: An animal model. Advanced Pharmaceutical Bulletin, 4(4), 401–404. https://doi.org/10.5681/apb.2014.059
    79. Somchit, N., Sanat, F., Gan, E. H., & Zuraini, A. (2004). Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid. Singapore Medical Journal, 45(11), 530–532. PMID: 15510325
    80. Sostres, C., Gargallo, C. J., & Lanas, A. (2010). Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Research & Therapy, 15(S3), S3. https://doi.org/10.1186/ar4175
    81. Sullivan, J. E., Farrar, H. C., & The Section on Clinical Pharmacology and Therapeutics, Committee on Drugs. (2021). Fever and antipyretic use in children. Pediatrics, 127(3), 580–587. https://doi.org/10.1542/peds.2010-3852
    82. Thakur, S., Thakur, V. K., Gupta, R. K., & Thakur, M. K. (2018). Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. Biomedicine & Pharmacotherapy, 107, 1561–1577. https://doi.org/10.1016/j.biopha.2018.07.027
    83. Thun, M. J., Henley, S. J., & Patrono, C. (2012). Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. Journal of the National Cancer Institute, 94(4), 252–266. https://doi.org/10.1093/jnci/94.4.252
    84. Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., & Jüni, P. (2011). Cardiovascular safety of non-steroidal anti-inflammatory drugs: Network meta-analysis. BMJ, 342, c7086. https://doi.org/10.1136/bmj.c7086
    85. Van Eck, N. J., & Waltman, L. (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84(2), 523–538. https://doi.org/10.1007/s11192-009-0146-3
    86. Waltman, L., Van Eck, N. J., & Wouters, P. (2012). The need for contextualized scientometric analysis: An editorial comment. Journal of Informetrics, 6(4), 458–460. https://doi.org/10.1016/j.joi.2012.07.001
    87. Wheatley, B. M., Cilwa, K. E., & Ding, K. (2019). Effect of NSAIDs on bone healing rates: A meta-analysis. Journal of the American Academy of Orthopaedic Surgeons, 27(17), e762–e772. https://doi.org/10.5435/JAAOS-D-17-00727
    88. Wider, W., Fauzi, M. A., Gan, S. W., Yap, C. C., Akmal Bin Ahmad Khadri, M. W., & Maidin, S. S. (2023). A bibliometric analysis of emerging adulthood in the context of higher education institutions: A psychological perspective. Heliyon, 9(6), e16988. https://doi.org/10.1016/j.heliyon.2023.e16988
    89. Wong, R. S. Y. (2019). Role of nonsteroidal anti-inflammatory drugs (NSAIDs) in cancer prevention and cancer promotion. Advances in Pharmacological Sciences, 2019, 3418975. https://doi.org/10.1155/2019/3418975
    90. Wright, J. M., Musini, V. M., & Gill, R. (2017). First-line drugs for hypertension. Cochrane Database of Systematic Reviews, 4(4), CD001841. https://doi.org/10.1002/14651858.CD001841.pub3
    91. Zakaria, Z. A., Balan, T., Azemi, A. K., Omar, M. H., Mohtarrudin, N., Ahmad, Z., Abdullah, M. N. H., Mohd Desa, M. N., Teh, L. K., & Salleh, M. Z. (2016). Mechanism(s) of action underlying the gastroprotective effect of ethyl acetate fraction obtained from the crude methanolic leaves extract of Muntingia calabura. BMC Complementary and Alternative Medicine, 16, Article 78. https://doi.org/10.1186/s12906-016-1041-0
    92. Zeng, L., Shi, Y., Subatijang, P., Zhang, L., Gao, J., Sun, R., & Jiang, K. (2025). Global research trends and hotspots in rheumatoid arthritis joint replacement: Bibliometric analysis and visualization study. Journal of Orthopaedics, 61(1), 72–84. https://doi.org/10.1016/j.jor.2024.09.017
    93. Zhang, M., Xia, F., Xia, S., Zhou, W., Zhang, Y., Han, X., Zhao, K., Feng, L., Dong, R., Tian, D., Yu, Y., & Liao, J. (2022). NSAID-associated small intestinal injury: An overview from animal model development to pathogenesis, treatment, and prevention. Frontiers in Pharmacology, 13, Article 818877. https://doi.org/10.3389/fphar.2022.818877
    94. Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Günther, K. P., & Tugwell, P. (2016). EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Annals of the Rheumatic Diseases, 69(8), 1371–1380. https://doi.org/10.1136/ard.2009.113100
    95. Zin, C. S., Nozid, N. R., Razak, A. A., Hashim, S. N., Mazlan, N. A., Daud, N., & Bux, S. H. (2020). Research on nonsteroidal anti-inflammatory drugs in Malaysia: A bibliometric analysis. Journal of Pharmacy and Bioallied Sciences, 12(S2), S707–S710. https://doi.org/10.4103/jpbs.JPBS_282_19
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 The Authors

How to cite

Alhatim, H., Alshadfan, H., Omar Fauzee, M. S., Zakaria, Z. A., & Hakim, M. N. (2025). Analyzing NSAIDS research trends: A six-year bibliometric study (2018-2023) on directions, themes, and dimensions. Multidisciplinary Reviews, 9(3), 2026130. https://doi.org/10.31893/multirev.2026130
Crossref
Scopus
Google Scholar
Europe PMC
  • Article viewed - 605
  • PDF downloaded - 164